Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

Last updated: March 20, 2023
Sponsor: Weill Medical College of Cornell University
Overall Status: Trial Not Available

Phase

N/A

Condition

Alzheimer's Disease

Dementia

Mild Cognitive Impairment

Treatment

N/A

Clinical Study ID

NCT03149380
1311014539
  • Ages > 14
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To evaluate the effectiveness of an online educational course on Alzheimer's disease (AD) prevention, treatment and caregiving.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • greater than or equal to 14 years old with a friend, family member or acquaintancewith Alzheimer's disease or memory loss, OR a person diagnosed with mild memory loss (including mild cognitive impairment due to Alzheimer's disease or mild Alzheimer'sdisease), OR an AD caregiver, OR healthcare providers, OR a medical student, collegestudent or high school student.

Exclusion

Exclusion Criteria:

  • < 14 years old, OR diagnosis of moderate or severe Alzheimer's disease

Study Design

Study Start date:
January 01, 2017
Estimated Completion Date:
October 31, 2024

Study Description

Alzheimer's Universe (www.AlzU.org) was created to provide online education about Alzheimer's disease (AD), with a focus on family members of people with AD, people with mild cognitive impairment due to AD and mild AD, caregivers, healthcare providers, medical students, college students and high school students. The website provides evidence-based courses with interactive lessons and activities that have been shown to increase knowledge about AD, willingness to participate in an AD prevention clinical trial, and intent to make specific lifestyle changes in effort to reduce AD risk.

Connect with a study center

  • Weill Medical College of Cornell University

    New York, New York 10021
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.